Clara E. E. Hanekamp
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Clara E. E. Hanekamp has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Bernd Heublein
1 shared publicationCees Visser
1 shared publicationH. Rolf Michels
From the Department of Cardiology, Catharina Hospital, Eindhoven, Netherlands
1 shared publicationHans Bonnier
1 shared publicationHans J. R. M. Bonnier
From the Department of Cardiology, Catharina Hospital, Eindhoven, Netherlands
1 shared publicationJacques J. Koolen
From the Department of Cardiology, Catharina Hospital, Eindhoven, Netherlands
1 shared publication
Latest Publications
- 1 May 2004
- Published by Elsevier in The American Journal of Cardiology
- Vol. 93 (10) , 1233-1237
Randomized comparison of balloon angioplasty versus silicon Carbon-Coated stent implantation for de novo lesions in small coronary arteries
- 1 May 2004
- Published by Elsevier in The American Journal of Cardiology
- Vol. 93 (10) , 1233-1237
Randomized comparison of balloon angioplasty versus silicon Carbon-Coated stent implantation for de novo lesions in small coronary arteries
- 2 March 1999
- Published by Wolters Kluwer Health in Circulation
- Vol. 99 (8) , 1015-1021
Comparison of Quantitative Coronary Angiography, Intravascular Ultrasound, and Coronary Pressure Measurement to Assess Optimum Stent Deployment
Background —Although intravascular ultrasound (IVUS) is the present standard for the evaluation of optimum stent deployment, this technique is expensive and not routinely feasible in most catheterization laboratories. Coronary pressure–derived myocardial fractional flow reserve (FFR myo ) is an easy, cheap, and rapidly obtainable index that is specific for the conductance of the epicardial coronary artery. In this study, we investigated the usefulness of coronary pressure measurement to predict optimum and suboptimum stent deployment. Methods and Results —In 30 patients, a Wiktor-i stent was implanted at different inflation pressures, starting at 6 atm and increasing step by step to 8, 10, 12, and 14 atm, if necessary. After every step, stent deployment was evaluated by quantitative coronary angiography (QCA), IVUS, and coronary pressure measurement. If any of the 3 techniques did not yield an optimum result, the next inflation was performed, and all 3 investigational modalities were repeated until optimum stent deployment was present by all of them or until the treating physician decided to accept the result. Optimum deployment according to QCA was finally achieved in 24 patients, according to IVUS in 17 patients, and also according to coronary pressure measurement in 17 patients. During the step-up, a total of 81 paired IVUS and coronary pressure measurements were performed, of which 91% yielded concordant results (ie, either an optimum or a suboptimum expansion of the stent by both techniques, P myo (48% and 46%, respectively). Conclusions —In this study, using a coil stent, both IVUS and coronary pressure measurement were of similar value with respect to the assessment of optimum stent deployment. Therefore, coronary pressure measurement can be used as a cheap and rapid alternative to IVUS for that purpose.
- 2 March 1999
- Published by Wolters Kluwer Health in Circulation
- Vol. 99 (8) , 1015-1021
Comparison of Quantitative Coronary Angiography, Intravascular Ultrasound, and Coronary Pressure Measurement to Assess Optimum Stent Deployment
Background —Although intravascular ultrasound (IVUS) is the present standard for the evaluation of optimum stent deployment, this technique is expensive and not routinely feasible in most catheterization laboratories. Coronary pressure–derived myocardial fractional flow reserve (FFR myo ) is an easy, cheap, and rapidly obtainable index that is specific for the conductance of the epicardial coronary artery. In this study, we investigated the usefulness of coronary pressure measurement to predict optimum and suboptimum stent deployment. Methods and Results —In 30 patients, a Wiktor-i stent was implanted at different inflation pressures, starting at 6 atm and increasing step by step to 8, 10, 12, and 14 atm, if necessary. After every step, stent deployment was evaluated by quantitative coronary angiography (QCA), IVUS, and coronary pressure measurement. If any of the 3 techniques did not yield an optimum result, the next inflation was performed, and all 3 investigational modalities were repeated until optimum stent deployment was present by all of them or until the treating physician decided to accept the result. Optimum deployment according to QCA was finally achieved in 24 patients, according to IVUS in 17 patients, and also according to coronary pressure measurement in 17 patients. During the step-up, a total of 81 paired IVUS and coronary pressure measurements were performed, of which 91% yielded concordant results (ie, either an optimum or a suboptimum expansion of the stent by both techniques, P myo (48% and 46%, respectively). Conclusions —In this study, using a coil stent, both IVUS and coronary pressure measurement were of similar value with respect to the assessment of optimum stent deployment. Therefore, coronary pressure measurement can be used as a cheap and rapid alternative to IVUS for that purpose.